Jon Serbousek, a 30-year veteran of the medical device and biotech industries, is the new President and CEO of Lewisville, Texas-based Orthofix Medical Inc. He will also serve on the company’s Board of Directors. Serbousek succeeds Brad Mason who had previously announced his plans to retire. While he has resigned from the Board of Directors, Mason will continue to be a consultant for Orthofix for the next 12 months to help ensure a smooth transition.
“We are grateful for Brad’s many contributions to Orthofix. Under his leadership a strong foundation was built that will serve Orthofix well in the years ahead,” said Ron Matricaria, Orthofix Chairman of the Board of Directors. “As we move into this next chapter, we are pleased to welcome Jon as President, CEO and Director. I am confident in Jon’s ability to deliver against our strategic business priorities. His vast experience in the medical device industry and focus on business growth and value creation will be a benefit to our organization.”
“I am appreciative of the opportunity to lead the talented team at Orthofix,” said Serbousek, whose past executive experience includes leadership roles at Medtronic, Biomet, and DePuy Orthopedics. “I firmly believe through the work of our dedicated team members around the world, we can deliver new levels of products, services and support for our surgeon customers and their patients.”
Serbousek has served in leadership positions at Biomet Inc., including Worldwide President of Biomet Biologics, Worldwide Group President of Orthopedics, and President of U.S. Orthopedics. Prior to joining Biomet, he held various general management positions within Medtronic Inc., including Worldwide Division President, Spine, and Worldwide Vice President and General Manager of Biologics for their Spine and Biologics business. He also spent 13 years with DePuy Orthopedics, a Johnson & Johnson company where he served in numerous roles of increasing responsibility, including Vice President of Marketing and Product Development and Vice President of Spinal Operations.
Serbousek commented to OTW, “In the short term I am focused on strengthening the spine business leadership and strategy, while assessing the needs within our Extremities business to secure our position for business execution and growth.”
